Compounds > voriconazole
Page last updated: 2024-08-25

voriconazole and deoxycholic acid

voriconazole has been researched along with deoxycholic acid in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (42.86)29.6817
2010's14 (50.00)24.3611
2020's2 (7.14)2.80

Authors

AuthorsStudies
Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C1
Perfect, JR1
Del Favero, A; Kibbler, C; Marciniak, A; Mauskopf, J; Morris, S; Rogers, T; Rotstein, C; Schlamm, H; Troke, P; Wenzel, R1
Böhme, A; Haas, A; Maschmeyer, G1
Ambegaonkar, AJ; Boucher, HW; Day, DL; Lewis, JS; Lubowski, TJ; Patterson, TF1
Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR1
Alarcón L, P; Camacho A, J; Cruces R, P; Donoso F, A1
Pemán, J; Zaragoza, R1
Hollenbach, E1
Barbabietola, G; Barker, K; Flynn, E; Marciniak, A; Oppenheim, BA; Roberts, C1
Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K1
Ayats, J; Fernández, N; Gasch, O; Santin, M1
Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M1
Clemons, KV; Schwartz, JA; Stevens, DA2
El-Hadidy, GN; El-Milligi, MF; Ibrahim, HK; Mohamed, MI1
Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R1
Aguirre, HD; Cataño, JC1
Benjamin, DK; Ericson, J; Manzoni, P1
Anaissie, E; Araujo, V; Arikan-Akdagli, S; Atalla, A; Bertz, H; Cappellano, P; Carlesse, F; Cesaro, S; Cornely, OA; de Souza, CA; Galvão Castro, C; Hamerschlak, N; Härter, G; Heinz, WJ; Herbrecht, R; Hermansen, NE; Hoenigl, M; Josting, A; Kindo, A; Lortholary, O; Marr, KA; Mossad, SB; Nucci, M; Ogunc, D; Pagano, L; Pasqualotto, AC; Queiroz-Telles, F; Salles, MJ; Schaller, M; Sheppard, DC; Solza, C; Troke, PF; Vehreschild, MJ; Velasco, E1
Amadori, F; Ciancia, EM; Doria, R; Flammini, S; Gemignani, G; Leonildi, A; Menichetti, F; Sanguinetti, M1
Barnes, R; Bow, E; Charbonneau, C; Earnshaw, S; Herbrecht, R; Kantecki, M; Maertens, J; McDade, C; Morrissey, O; Schlamm, H; Slavin, M; Weinstein, D1
Escrig, C; Herbrecht, R; Kuessner, D; Pooley, N; Posthumus, J1
Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L1
Díaz, MC; Luppi, M; Olivares, R1
Fica, A; Leiva Hernández, M; Salgueiro C, C; Téllez R, M1
Clerkin, P; Kuzmic, B; Laningham, F; McCarty, J; Naeem, F1
Chen, Y; Harypursat, V; Lan, K; Lu, Y; Wu, Y; Xu, X; Yang, T; Yu, J; Zeng, Q; Zhang, W; Zhao, T; Zhou, G1

Reviews

7 review(s) available for voriconazole and deoxycholic acid

ArticleYear
Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2004
[Update on therapy of invasive mycoses in hematology and oncology].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis

2005
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
    Mycoses, 2008, Volume: 51 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2008
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2011
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
    Early human development, 2013, Volume: 89 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole

2013
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.
    Current medical research and opinion, 2018, Volume: 34, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Network Meta-Analysis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole

2018

Trials

1 trial(s) available for voriconazole and deoxycholic acid

ArticleYear
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Nov-15, Volume: 41, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2005

Other Studies

20 other study(ies) available for voriconazole and deoxycholic acid

ArticleYear
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2002
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost Savings; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Health Care Costs; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole

2005
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
    Pharmacotherapy, 2005, Volume: 25, Issue:6

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Economics, Pharmaceutical; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2005
[Invasive multisystemic aspergillosis in an immunocompetent child: case report].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2006, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole

2006
A multi-centre comparison of nursing staff time required for the preparation and administration of liposomal amphotericin B and amphotericin B deoxycholate vs. voriconazole.
    Journal of clinical nursing, 2009, Volume: 18, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Costs and Cost Analysis; Deoxycholic Acid; Drug Combinations; Humans; Pyrimidines; Time Management; Triazoles; United Kingdom; Voriconazole

2009
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Feb-01, Volume: 48, Issue:3

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole

2009
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole

2011
Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation.
    Drug development and industrial pharmacy, 2012, Volume: 38, Issue:1

    Topics: Administration, Topical; Animals; Antifungal Agents; Chemistry, Pharmaceutical; Deoxycholic Acid; Drug Carriers; Drug Stability; Emulsions; Guinea Pigs; Hydrogen-Ion Concentration; Oleic Acid; Permeability; Plant Oils; Polyethylene Glycols; Polysorbates; Pyrimidines; Rheology; Solubility; Surface-Active Agents; Triazoles; Voriconazole; Water; Waxes

2012
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
    Mycoses, 2013, Volume: 56, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts

2013
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cyclophosphamide; Deoxycholic Acid; Drug Combinations; Echinocandins; Endothelial Cells; Heart; Immunosuppression Therapy; Intercellular Adhesion Molecule-1; Kidney; Lipopeptides; Lung; Male; Mice; Nephrosis; Neuroaspergillosis; P-Selectin; Pyrimidines; Triazoles; Voriconazole

2012
Disseminated paracoccidioidomycosis.
    The American journal of tropical medicine and hygiene, 2013, Volume: 88, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Male; Paracoccidioidomycosis; Pyrimidines; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole

2013
Improvement in the outcome of invasive fusariosis in the last decade.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fusariosis; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2014
[Histoplasmosis: the multiple sides of an uncommon disease].
    Le infezioni in medicina, 2015, Volume: 23, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Female; Hepatitis B, Chronic; Hepatitis D, Chronic; Histoplasmosis; Homosexuality, Male; Humans; Immunocompromised Host; Invasive Fungal Infections; Italy; Male; Risk Factors; Thailand; Treatment Outcome; Voriconazole

2015
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
    Clinical therapeutics, 2015, Jun-01, Volume: 37, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cost Savings; Decision Trees; Deoxycholic Acid; Drug Combinations; Echinocandins; Febrile Neutropenia; Galactose; Health Care Costs; Health Resources; Humans; Immunocompromised Host; Lipopeptides; Mannans; Survival Rate; Voriconazole

2015
Impact of Antifungal Compounds on Viability and Anti-
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole

2019
[Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2018, Volume: 35, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fusariosis; Humans; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole

2018
[Cerebral cryptococcosis and immune reconstitution inflammatory syndrome. Case report].
    Revista medica de Chile, 2018, Volume: 146, Issue:12

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Middle Aged; Voriconazole

2018
Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis.
    The Pediatric infectious disease journal, 2021, 03-01, Volume: 40, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Child; Coccidioides; Coccidioidomycosis; Deoxycholic Acid; Drug Combinations; Humans; Meningitis, Fungal; Nitriles; Pyridines; Salvage Therapy; Triazoles; Voriconazole

2021
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
    BMC infectious diseases, 2022, Aug-08, Volume: 22, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cohort Studies; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; HIV Infections; Humans; Infertility; Meningitis, Cryptococcal; Prospective Studies; Voriconazole

2022